CSL is a global biotechnology leader that has delivered life-saving and life-improving therapies for over a century. Through its businesses CSL Behring, CSL Seqirus, CSL Plasma and CSL Vifor, it develops plasma-derived and recombinant therapies for rare and serious diseases, innovative vaccines, and treatments for iron deficiency and kidney disease, backed by world-class R&D, a strong sustainability focus and inclusive, values-driven careers.
CSL is a global biotechnology leader that has delivered life-saving and life-improving therapies for over a century. Through its businesses CSL Behring, CSL Seqirus, CSL Plasma and CSL Vifor, it develops plasma-derived and recombinant therapies for rare and serious diseases, innovative vaccines, and treatments for iron deficiency and kidney disease, backed by world-class R&D, a strong sustainability focus and inclusive, values-driven careers.
CSL is a global biotechnology leader that has delivered life-saving and life-improving therapies for over a century. Through its businesses CSL Behring, CSL Seqirus, CSL Plasma and CSL Vifor, it develops plasma-derived and recombinant therapies for rare and serious diseases, innovative vaccines, and treatments for iron deficiency and kidney disease, backed by world-class R&D, a strong sustainability focus and inclusive, values-driven careers.